全文获取类型
收费全文 | 6877篇 |
免费 | 384篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 292篇 |
妇产科学 | 214篇 |
基础医学 | 730篇 |
口腔科学 | 157篇 |
临床医学 | 1200篇 |
内科学 | 981篇 |
皮肤病学 | 73篇 |
神经病学 | 521篇 |
特种医学 | 217篇 |
外科学 | 668篇 |
综合类 | 69篇 |
一般理论 | 11篇 |
预防医学 | 960篇 |
眼科学 | 100篇 |
药学 | 555篇 |
中国医学 | 13篇 |
肿瘤学 | 494篇 |
出版年
2023年 | 27篇 |
2022年 | 26篇 |
2021年 | 110篇 |
2020年 | 67篇 |
2019年 | 121篇 |
2018年 | 147篇 |
2017年 | 104篇 |
2016年 | 113篇 |
2015年 | 144篇 |
2014年 | 213篇 |
2013年 | 302篇 |
2012年 | 444篇 |
2011年 | 482篇 |
2010年 | 328篇 |
2009年 | 224篇 |
2008年 | 465篇 |
2007年 | 509篇 |
2006年 | 530篇 |
2005年 | 478篇 |
2004年 | 460篇 |
2003年 | 452篇 |
2002年 | 494篇 |
2001年 | 93篇 |
2000年 | 95篇 |
1999年 | 82篇 |
1998年 | 84篇 |
1997年 | 83篇 |
1996年 | 54篇 |
1995年 | 58篇 |
1994年 | 45篇 |
1993年 | 35篇 |
1992年 | 31篇 |
1991年 | 26篇 |
1990年 | 25篇 |
1989年 | 24篇 |
1988年 | 28篇 |
1987年 | 26篇 |
1986年 | 27篇 |
1985年 | 25篇 |
1984年 | 20篇 |
1983年 | 24篇 |
1982年 | 19篇 |
1981年 | 25篇 |
1980年 | 23篇 |
1979年 | 15篇 |
1978年 | 15篇 |
1977年 | 17篇 |
1976年 | 11篇 |
1974年 | 23篇 |
1973年 | 11篇 |
排序方式: 共有7319条查询结果,搜索用时 62 毫秒
81.
Judy F Flax Teresa Realpe-Bonilla Linda S Hirsch Linda M Brzustowicz Christopher W Bartlett Paula Tallal 《J. Speech Lang. Hear. Res.》2003,46(3):530-543
Two family aggregation studies report the occurrence and co-occurrence of oral language impairments (LIs) and reading impairments (RIs). Study 1 examined the occurrence (rate) of LI and RI in children with specific language impairment (SLI probands), a matched control group, and all nuclear family members. Study 2 included a larger sample of SLI probands, as well as their nuclear and extended family members. Probands and their family members who met specific criteria were classified as language and/or reading impaired based on current testing. In Study 1, the rates of LI and RI for nuclear family members (excluding probands) were significantly higher than those for control family members. In the SLI families, affected family members were more likely to have both LI and RI than either impairment alone. In Study 2, 68% of the SLI probands also met the diagnostic classification for RI. The language and RI rates for the other family members, excluding probands, were 25% and 23% respectively, with a high degree of co-occurrence of LI and RI (46%) in affected individuals. Significant sex ratio differences were found across generations in the families of SLI probands. There were more male than female offspring in these families, and more males than females were found to have both LIs and RIs. Results demonstrate that when LIs occur within families of SLI probands, these impairments generally co-occur with RIs. Our data are also consistent with prior findings that males show impairments more often than females. 相似文献
82.
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. 总被引:1,自引:0,他引:1
Julie R Thibodeaux Roger G Hanson John M Rogers Brian E Grey Brenda D Barbee Judy H Richards John L Butenhoff Lisa A Stevenson Christopher Lau 《Toxicological sciences》2003,74(2):369-381
The maternal and developmental toxicities of perfluorooctane sulfonate (PFOS, C8F17SO3-) were evaluated in the rat and mouse. PFOS is an environmentally persistent compound used as a surfactant and occurs as a degradation product of both perfluorooctane sulfonyl fluoride and substituted perfluorooctane sulfonamido components found in many commercial and consumer applications. Pregnant Sprague-Dawley rats were given 1, 2, 3, 5, or 10 mg/kg PFOS daily by gavage from gestational day (GD) 2 to GD 20; CD-1 mice were similarly treated with 1, 5, 10, 15, and 20 mg/kg PFOS from GD 1 to GD 17. Controls received 0.5% Tween-20 vehicle (1 ml/kg for rats and 10 ml/kg for mice). Maternal weight gain, food and water consumption, and serum chemistry were monitored. Rats were euthanized on GD 21 and mice on GD 18. PFOS levels in maternal serum and in maternal and fetal livers were determined. Maternal weight gains in both species were suppressed by PFOS in a dose-dependent manner, likely attributed to reduced food and water intake. Serum PFOS levels increased with dosage, and liver levels were approximately fourfold higher than serum. Serum thyroxine (T4) and triiodothyronine (T3) in the PFOS-treated rat dams were significantly reduced as early as one week after chemical exposure, although no feedback response of thyroid-stimulating hormone (TSH) was observed. A similar pattern of reduction in T4 was also seen in the pregnant mice. Maternal serum triglycerides were significantly reduced, particularly in the high-dose groups, although cholesterol levels were not affected. In the mouse dams, PFOS produced a marked enlargement of the liver at 10 mg/kg and higher dosages. In the rat fetuses, PFOS was detected in the liver but at levels nearly half of those in the maternal counterparts, regardless of administered doses. In both rodent species, PFOS did not alter the numbers of implantations or live fetuses at term, although small deficits in fetal weight were noted in the rat. A host of birth defects, including cleft palate, anasarca, ventricular septal defect, and enlargement of the right atrium, were seen in both rats and mice, primarily in the 10 and 20 mg/kg dosage groups, respectively. Our results demonstrate both maternal and developmental toxicity of PFOS in the rat and mouse. 相似文献
83.
Kloster KL Judy MM Matthews JL Utecht RE Burbach JA Vaska KJ 《Lasers in surgery and medicine》2000,26(3):316-322
BACKGROUND AND OBJECTIVE: We are currently working with a novel class of photoactivated 4-amino substituted 1,8-naphthalimide compounds for tissue bonding. With promising results in other tissues, we are pursuing potential vascular applications. This study focused on determining the appropriate compound formulation(s), concentration, and exposure times to optimize penetration of the heterogeneous arterial wall. STUDY DESIGN/MATERIALS AND METHODS: Segments of atheromatous rabbit carotid artery were immersed in hydrophilic or lipophilic forms of the compound, then frozen, cryosectioned, and examined by confocal microscopy. RESULTS: The hydrophilic compound exhibited preferential localization within the intima and media and limited presence in the adventitia. Conversely, the lipophilic compound concentrated in the intima and adventitia with virtual exclusion from the media. Exposure to both forms resulted in complete penetration of the arterial wall. CONCLUSION: These results extend our knowledge and permit a more practical approach to potential vascular applications using these photoactivated compounds for tissue bonding. 相似文献
84.
85.
Frequency of the ATM IVS10-6T→G variant in Australian multiple-case breast cancer families 下载免费PDF全文
86.
Cara L Frankenfeld Anne McTiernan Erin J Aiello Wendy K Thomas Kristin LaCroix Judy Schramm Stephen M Schwartz Victoria L Holt Johanna W Lampe 《Cancer epidemiology, biomarkers & prevention》2004,13(7):1156-1162
Circulating hormones are associated with mammographic density, an intermediate marker of breast cancer risk. Differences in circulating hormones, including estrone and testosterone, have been observed in premenopausal women based on their capacity to metabolize daidzein, an isoflavone found predominantly in soybeans. Equol and O-desmethylangolensin (O-DMA) are products of intestinal bacterial metabolism of daidzein. There is interindividual variability in the capacity to produce daidzein metabolites; individuals can be equol producers or non-producers and O-DMA producers or non-producers. We tested the hypothesis that daidzein-metabolizing phenotypes are associated with mammographic density. Participants were recruited from among 92 sedentary, postmenopausal women, ages 50 to 75 years, who participated in a 1-year physical activity intervention. Pre-intervention mammographic density was determined using a computer-assisted, gray-scale thresholding technique. Fifty-five of these women consumed supplemental soy protein (>10 mg daidzein/d) for 3 days and collected a first-void urine sample on the fourth day to determine daidzein-metabolizing phenotypes. Equol and O-DMA concentrations were measured using gas chromatography-mass spectrometry. Associations between daidzein-metabolizing phenotypes and percent mammographic density were adjusted for age, maximum adult weight, gravidity, family history of breast cancer, and serum follicle-stimulating hormone and free testosterone concentrations. Mammographic density was 39% lower in equol producers compared with non-producers (P = 0.04). O-DMA producers had mammographic density 69% greater than non-producers (P = 0.05). These results suggest that particular intestinal bacterial profiles are associated with postmenopausal mammographic density, and these associations are not entirely explained by differences in reproductive or anthropometric characteristics or circulating hormones. 相似文献
87.
Douglas S Hawkins Julie R Park Blythe G Thomson Judy L Felgenhauer John S Holcenberg Eduard H Panosyan Vassilios I Avramis 《Clinical cancer research》2004,10(16):5335-5341
PURPOSE: Asparaginase therapy is an important component in the treatment of children with acute lymphoblastic leukemia. Polyethylene glycol-conjugated asparaginase (PEG-ASNase) has significant pharmacological advantages over native Escherichia coli asparaginase. We investigated the pharmacokinetics of PEG-ASNase, presence of antibodies to PEG-ASNase, and concentrations of asparagine in serum and cerebrospinal fluid (CSF) in combination chemotherapy for relapsed pediatric acute lymphoblastic leukemia. EXPERIMENTAL DESIGN: Twenty-eight pediatric patients with relapsed medullary (n = 16) and extramedullary (n = 11) acute lymphoblastic leukemia were enrolled at three pediatric institutions and had at least two serum and CSF samples obtained for analysis. Patients received induction therapy (including PEG-ASNase 2500 IU/m2 intramuscularly weekly on days 2, 9, 16, and 23) and intensification therapy (including PEG-ASNase 2500 IU/m2 intramuscularly once on day 7). Serum samples were obtained weekly during induction and intensification. CSF samples were obtained during therapeutic lumbar punctures during induction and intensification. RESULTS: Weekly PEG-ASNase therapy resulted in PEG-ASNase activity of >0.1 IU/ml in 91-100% of patients throughout induction. During intensification, PEG-ASNase on day 7 resulted in PEG-ASNase activity >0.1 IU/ml in 94% and 80% of patients on days 14 and 21, respectively. Serum and CSF asparagine depletion was observed and maintained during induction and intensification in the majority of samples. PEG-ASNase antibody was observed in only 3 patients. CONCLUSIONS: Intensive PEG-ASNase therapy in the treatment of relapsed acute lymphoblastic leukemia reliably results in high-level serum PEG-ASNase activity, and asparagine depletion in serum and CSF is usually achieved. Incorporation of intensive PEG-ASNase in future trials for recurrent acute lymphoblastic leukemia is warranted. 相似文献
88.
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. 总被引:4,自引:0,他引:4
Roger J Packer James G Gurney Judy A Punyko Sarah S Donaldson Peter D Inskip Marilyn Stovall Yutaka Yasui Ann C Mertens Charles A Sklar H Stacy Nicholson Lonnie K Zeltzer Joseph P Neglia Leslie L Robison 《Journal of clinical oncology》2003,21(17):3255-3261
PURPOSE: To describe the neurologic and neurosensory deficits in children with brain tumors (BTs), compare incidence of these deficits with that of a sibling control group, and evaluate the factors associated with the development of these deficits. PATIENTS AND METHODS: Detailed questionnaires were completed on 1,607 patients diagnosed between 1970 and 1986 with a primary CNS tumor. Neurosensory and neurologic dysfunctions were assessed and results compared with those of a sibling control group. Medical records on all patients were abstracted, including radiotherapy dose and volume. RESULTS: Seventeen percent of patients developed neurosensory impairment. Relative to the sibling comparison group, patients surviving BTs were at elevated risk for hearing impairments (relative risk [RR], 17.3; P = <.0001), legal blindness in one or both eyes (RR, 14.8; P = <.0001), cataracts (RR, 11.9; P = <.0001), and double vision (RR, 8.8; P = <.0001). Radiation exposure greater than 50 Gy to the posterior fossa was associated with a higher likelihood of developing any hearing impairment. Coordination and motor control problems were reported in 49% and 26%, respectively, of survivors. Children receiving at least 50 Gy to the frontal brain regions had a moderately elevated risk for motor problems (RR, 2.0; P <.05). Seizure disorders were reported in 25% of patients, including 6.5% who had a late first occurrence. Radiation dose of 30 Gy or more to any cortical segment of the brain was associated with a two-fold elevated risk for a late seizure disorder. CONCLUSION: Children surviving BTs are at significant risk for both early and late neurologic or neurosensory sequelae. These sequelae need to be prospectively monitored. 相似文献
89.
Lindon J. Eaves Judy L. Silberg Joanne M. Meyer Hermine H. Maes Emily Simonoff rew Pickles Michael Rutter Chandra A. Reynolds rew C. Heath Kimberly R. Truett Michael C. Neale Marilyn T. Erikson Rolf Loeber John K. Hewitt 《Journal of child psychology and psychiatry, and allied disciplines》1997,38(8):965-980
90.
Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration 总被引:2,自引:0,他引:2 下载免费PDF全文